Matches in SemOpenAlex for { <https://semopenalex.org/work/W3148979730> ?p ?o ?g. }
- W3148979730 endingPage "152" @default.
- W3148979730 startingPage "140" @default.
- W3148979730 abstract "To design and synthesize a novel class of antitumor agents, featuring the 3, 5-substituted indolin-2-one framework. Based on enzyme binding features of (Z)-SU5402, introducing a β-pyrrole group at the 3-position of the indolin-2-one core, a series of novel 3,5-substituted indolin-2-ones were designed and synthesized. Four human carcinoma cell lines of A-431, A-549, MDA-MB-468, and Autosomal Dominant Polycystic Kidney disease were chosen for the cell proliferation assay. Twenty new compounds (1a–t) with E configuration have been designed, synthesized and bioassayed. Their structural features were determined by nuclear magnetic resonance (NMR) spectra, low- and high-resolution mass spectra, and confirmed by X-ray crystallography. Although the enzyme assay showed a weak inhibition effect against the epidermal growth factor receptor, vascular endothelial growth factor receptor, fibroblast growth factor receptor and platelet-derived growth factor receptor tyrosine kinases, the cell-based antitumor activity was promising. Compounds 1g and 1h showed higher inhibitory activity toward the A-549 and MDA-MB-468 cell lines with IC50 of 0.065–9.4 umol/L. This study provides a new template for further development of potent antitumor drugs." @default.
- W3148979730 created "2021-04-13" @default.
- W3148979730 creator A5001392142 @default.
- W3148979730 creator A5007495967 @default.
- W3148979730 creator A5019932151 @default.
- W3148979730 creator A5034965904 @default.
- W3148979730 creator A5041720098 @default.
- W3148979730 creator A5042489382 @default.
- W3148979730 creator A5055540928 @default.
- W3148979730 creator A5064268664 @default.
- W3148979730 creator A5081309131 @default.
- W3148979730 creator A5085945579 @default.
- W3148979730 creator A5089348951 @default.
- W3148979730 date "2007-01-01" @default.
- W3148979730 modified "2023-10-03" @default.
- W3148979730 title "Design, synthesis, antitumor evaluations and molecular modeling studies of novel 3,5-substituted indolin-2-one derivatives" @default.
- W3148979730 cites W1964591445 @default.
- W3148979730 cites W1967554767 @default.
- W3148979730 cites W1969855058 @default.
- W3148979730 cites W1969974964 @default.
- W3148979730 cites W1970611913 @default.
- W3148979730 cites W1973815940 @default.
- W3148979730 cites W1979046104 @default.
- W3148979730 cites W1983790923 @default.
- W3148979730 cites W1987469796 @default.
- W3148979730 cites W1988506250 @default.
- W3148979730 cites W1992388470 @default.
- W3148979730 cites W2005904989 @default.
- W3148979730 cites W2008517160 @default.
- W3148979730 cites W2014787161 @default.
- W3148979730 cites W2032359283 @default.
- W3148979730 cites W2034919226 @default.
- W3148979730 cites W2057409901 @default.
- W3148979730 cites W2064973618 @default.
- W3148979730 cites W2069637592 @default.
- W3148979730 cites W2082308457 @default.
- W3148979730 cites W2084612167 @default.
- W3148979730 cites W2114918609 @default.
- W3148979730 cites W2130479394 @default.
- W3148979730 cites W2158534713 @default.
- W3148979730 cites W2166052839 @default.
- W3148979730 cites W2950131855 @default.
- W3148979730 doi "https://doi.org/10.1111/j.1745-7254.2006.00473.x" @default.
- W3148979730 hasPublicationYear "2007" @default.
- W3148979730 type Work @default.
- W3148979730 sameAs 3148979730 @default.
- W3148979730 citedByCount "2" @default.
- W3148979730 countsByYear W31489797302012 @default.
- W3148979730 crossrefType "journal-article" @default.
- W3148979730 hasAuthorship W3148979730A5001392142 @default.
- W3148979730 hasAuthorship W3148979730A5007495967 @default.
- W3148979730 hasAuthorship W3148979730A5019932151 @default.
- W3148979730 hasAuthorship W3148979730A5034965904 @default.
- W3148979730 hasAuthorship W3148979730A5041720098 @default.
- W3148979730 hasAuthorship W3148979730A5042489382 @default.
- W3148979730 hasAuthorship W3148979730A5055540928 @default.
- W3148979730 hasAuthorship W3148979730A5064268664 @default.
- W3148979730 hasAuthorship W3148979730A5081309131 @default.
- W3148979730 hasAuthorship W3148979730A5085945579 @default.
- W3148979730 hasAuthorship W3148979730A5089348951 @default.
- W3148979730 hasBestOaLocation W31489797301 @default.
- W3148979730 hasConcept C146285616 @default.
- W3148979730 hasConcept C14858245 @default.
- W3148979730 hasConcept C167734588 @default.
- W3148979730 hasConcept C170493617 @default.
- W3148979730 hasConcept C185592680 @default.
- W3148979730 hasConcept C2776362946 @default.
- W3148979730 hasConcept C2777025900 @default.
- W3148979730 hasConcept C2779438470 @default.
- W3148979730 hasConcept C42362537 @default.
- W3148979730 hasConcept C502942594 @default.
- W3148979730 hasConcept C54355233 @default.
- W3148979730 hasConcept C55493867 @default.
- W3148979730 hasConcept C71240020 @default.
- W3148979730 hasConcept C81885089 @default.
- W3148979730 hasConcept C86803240 @default.
- W3148979730 hasConceptScore W3148979730C146285616 @default.
- W3148979730 hasConceptScore W3148979730C14858245 @default.
- W3148979730 hasConceptScore W3148979730C167734588 @default.
- W3148979730 hasConceptScore W3148979730C170493617 @default.
- W3148979730 hasConceptScore W3148979730C185592680 @default.
- W3148979730 hasConceptScore W3148979730C2776362946 @default.
- W3148979730 hasConceptScore W3148979730C2777025900 @default.
- W3148979730 hasConceptScore W3148979730C2779438470 @default.
- W3148979730 hasConceptScore W3148979730C42362537 @default.
- W3148979730 hasConceptScore W3148979730C502942594 @default.
- W3148979730 hasConceptScore W3148979730C54355233 @default.
- W3148979730 hasConceptScore W3148979730C55493867 @default.
- W3148979730 hasConceptScore W3148979730C71240020 @default.
- W3148979730 hasConceptScore W3148979730C81885089 @default.
- W3148979730 hasConceptScore W3148979730C86803240 @default.
- W3148979730 hasIssue "1" @default.
- W3148979730 hasLocation W31489797301 @default.
- W3148979730 hasOpenAccess W3148979730 @default.
- W3148979730 hasPrimaryLocation W31489797301 @default.
- W3148979730 hasRelatedWork W1995425733 @default.
- W3148979730 hasRelatedWork W2013631005 @default.
- W3148979730 hasRelatedWork W2024146687 @default.